Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

815 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GY, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Talasaz AH, et al. Among authors: vaduganathan m. medRxiv [Preprint]. 2021 May 4:2021.05.03.21256468. doi: 10.1101/2021.05.03.21256468. medRxiv. 2021. Update in: J Am Coll Cardiol. 2021 Oct 19;78(16):1635-1654. doi: 10.1016/j.jacc.2021.08.021. PMID: 33972948 Free PMC article. Updated. Preprint.
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Talasaz AH, et al. Among authors: vaduganathan m. Nat Rev Cardiol. 2024 Aug;21(8):574-592. doi: 10.1038/s41569-024-01003-3. Epub 2024 Mar 20. Nat Rev Cardiol. 2024. PMID: 38509244 Review.
SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome.
Beers BD, Chebrolu B, Stern GM, Buckley LF, Vaduganathan M, Bhatt DL, Bernier TD. Beers BD, et al. Among authors: vaduganathan m. Am J Cardiovasc Drugs. 2024 Nov;24(6):841-844. doi: 10.1007/s40256-024-00687-9. Epub 2024 Oct 9. Am J Cardiovasc Drugs. 2024. PMID: 39382621 No abstract available.
Electronically Delivered, Cardiovascular-Focused Messaging to Improve Influenza Vaccination: Rationale, Design, and Baseline Characteristics of the KP-VACCINATE Megatrial.
Bhatt AS, Go AS, Parikh RV, Ballance Z, Tan TC, Marafino BJ, Hu H, Mummert M, Ambrosy AP, Hernandez-Diaz G, Fitch R, Patel S, Biering-Sørensen T, Claggett BL, Johansen ND, Jones A, Ku IA, Solomon SD, Vaduganathan M, Galper BZ, Lee KL, Berry NC; KP-VACCINATE Investigators. Bhatt AS, et al. Among authors: vaduganathan m. Am Heart J. 2025 Jun 18:S0002-8703(25)00196-6. doi: 10.1016/j.ahj.2025.06.007. Online ahead of print. Am Heart J. 2025. PMID: 40541687
Finerenone According to Frailty in Heart Failure: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial.
Butt JH, Jhund PS, Henderson AD, Claggett BL, Chiang CE, Linssen GCM, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, von Lewinski D, Lay-Flurrie J, Scalise A, Rohwedder K, Desai AS, Lam CSP, Senni M, Shah SJ, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Butt JH, et al. Among authors: vaduganathan m. JAMA Cardiol. 2025 Jun 18:e251775. doi: 10.1001/jamacardio.2025.1775. Online ahead of print. JAMA Cardiol. 2025. PMID: 40531488 Free PMC article.
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART Analysis.
Ostrominski JW, Filippatos G, Claggett BL, Miao ZM, Desai AS, Jhund PS, D Henderson A, Scheerer MF, Rohwedder K, Amarante F, Brinker M, Lay-Flurrie J, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M. Ostrominski JW, et al. Among authors: vaduganathan m. JACC Heart Fail. 2025 Jun 11;13(8):102497. doi: 10.1016/j.jchf.2025.03.041. Online ahead of print. JACC Heart Fail. 2025. PMID: 40505158 Free article.
Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global Relevance.
Yang M, Kondo T, Dewan P, Desai AS, Sibulo AS Jr, Lam CSP, Chiang CE, Gomez EA, Martinez FA, Thierer J, Nicolau JC, Kerr Saraiva JF, Kitakaze M, Packer M, Vaduganathan M, Vinh PN, Abraham WT, Jhund PS, Solomon SD, McMurray JJV. Yang M, et al. Among authors: vaduganathan m. J Am Heart Assoc. 2025 Jun 17;14(12):e037810. doi: 10.1161/JAHA.124.037810. Epub 2025 Jun 11. J Am Heart Assoc. 2025. PMID: 40497494 Free article.
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials.
Lassen MCH, Ostrominski JW, Claggett BL, Neuen BL, Beldhuis IE, Butt J, Biering-Sørensen T, Desai AS, Lewis EF, Jhund PS, Mc Causland F, Anand IS, Pfeffer MA, Pitt B, Zannad F, Zile MR, McMurray JJV, Solomon SD, Vaduganathan M. Lassen MCH, et al. Among authors: vaduganathan m. JACC Heart Fail. 2025 Jun 9;13(8):102498. doi: 10.1016/j.jchf.2025.03.042. Online ahead of print. JACC Heart Fail. 2025. PMID: 40494011
815 results